{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:33:18Z","timestamp":1792693998638,"version":"4.5.0"},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1111\/dth.12656","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T05:00:18Z","timestamp":1538110818000},"page":"e12656","source":"Crossref","is-referenced-by-count":116,"title":["Tofacitinib for the treatment of lichen planopilaris: A case series"],"prefix":"10.1155","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7822-394X","authenticated-orcid":false,"given":"Christine C.","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Dermatology; Columbia University Medical Center; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Khanna","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians and Surgeons; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Sallee","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Columbia University Medical Center; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Christiano","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Columbia University Medical Center; New York New York"},{"name":"Department of Genetics and Development; Columbia University; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.","family":"Bordone","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Columbia University Medical Center; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"issue":"3","key":"10.1111\/dth.12656-BIB0001|dth12656-cit-0001","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaad.2009.08.054","article-title":"Hydroxychloroquine and lichen planopilaris: Efficacy and introduction of lichen Planopilaris Activity Index scoring system","volume":"62","author":"Chiang","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1111\/dth.12656-BIB0002|dth12656-cit-0002","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamadermatol.2015.1520","article-title":"Tofacitinib citrate for the treatment of vitiligo","volume":"151","author":"Craiglow","year":"2015","journal-title":"JAMA Dermatology"},{"issue":"15","key":"10.1111\/dth.12656-BIB0003|dth12656-cit-0003","article-title":"Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata","volume":"1","author":"Kennedy","year":"2016","journal-title":"JCI Insight"},{"issue":"2","key":"10.1111\/dth.12656-BIB0004|dth12656-cit-0004","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/path.4233","article-title":"Lichen planopilaris is characterized by immune privilege collapse of the hair follicles epithelial stem cell niche","volume":"231","author":"Harries","year":"2013","journal-title":"The Journal of Pathology"},{"issue":"1","key":"10.1111\/dth.12656-BIB0005|dth12656-cit-0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaad.2016.09.007","article-title":"Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients","volume":"76","author":"Liu","year":"2017","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"15","key":"10.1111\/dth.12656-BIB0006|dth12656-cit-0006","doi-asserted-by":"crossref","first-page":"e89790","DOI":"10.1172\/jci.insight.89790","article-title":"Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata","volume":"1","author":"Mackay-Wiggan","year":"2016","journal-title":"JCI Insight"},{"issue":"2","key":"10.1111\/dth.12656-BIB0007|dth12656-cit-0007","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jdv.12081","article-title":"Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis","volume":"28","author":"Mamolo","year":"2015","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"10","key":"10.1111\/dth.12656-BIB0008|dth12656-cit-0008","doi-asserted-by":"crossref","first-page":"e0164080","DOI":"10.1371\/journal.pone.0164080","article-title":"JAK3 as an emerging target for topical treatment of inflammatory skin diseases","volume":"11","author":"Medeiros","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1111\/dth.12656-BIB0009|dth12656-cit-0009","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2133.2012.11168.x","article-title":"Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: A phase 2b randomized placebo-controlled dose-ranging study","volume":"167","author":"Papp","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"12","key":"10.1111\/dth.12656-BIB0010|dth12656-cit-0010","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/jdv.12139","article-title":"Treatment of frontal fibrosing alopecia and lichen planopilaris: A systematic review","volume":"27","author":"R\u00e1cz","year":"2013","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"4","key":"10.1111\/dth.12656-BIB0011|dth12656-cit-0011","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/11596960-000000000-00000","article-title":"Cicatricial (scarring) alopecias","volume":"13","author":"Rongioletti","year":"2012","journal-title":"American Journal of Clinical Dermatology"},{"issue":"9","key":"10.1111\/dth.12656-BIB0012|dth12656-cit-0012","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nature Medicine"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12656","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12656\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:57:54Z","timestamp":1671818274000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12656","archive":["Portico"],"relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,27]]}}}